论文部分内容阅读
作者认为“中国肿瘤登记地区2006年肿瘤发病和死亡资料分析”一文,是基于人群肿瘤登记,该报告样本量是目前中国最大,质量控制也是较严谨的,时效上考虑相对而言也是最新的。文章还对该报告涉及的肿瘤登记工作及肿瘤登记数据的代表性等问题进行了评论。
According to the author, the article “Analysis of Cancer Incidence and Death Data in China’s Cancer Registry Area in 2006” is based on the registration of population tumors. The sample size of the report is the largest in China and the quality control is more stringent, and the timeliness is relatively new of. The article also comments on such issues as the registration of tumors involved in the report and the representativeness of the tumor registration data.